BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24889917)

  • 1. Transport and Golgi organisation protein 1 is a novel tumour progressive factor in oral squamous cell carcinoma.
    Sasahira T; Kirita T; Yamamoto K; Ueda N; Kurihara M; Matsushima S; Bhawal UK; Bosserhoff AK; Kuniyasu H
    Eur J Cancer; 2014 Aug; 50(12):2142-51. PubMed ID: 24889917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell chymase promotes angiogenesis and lymphangiogenesis mediated by activation of melanoma inhibitory activity gene family members in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Shimomura H; Bosserhoff AK; Kirita T
    Int J Oncol; 2020 May; 56(5):1093-1100. PubMed ID: 32319583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.
    Sasahira T; Kurihara-Shimomura M; Shimomura H; Bosserhoff AK; Kirita T
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1659-1672. PubMed ID: 33620575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma.
    Sasahira T; Kirita T; Kurihara M; Yamamoto K; Bhawal UK; Bosserhoff AK; Kuniyasu H
    Eur J Cancer; 2010 Aug; 46(12):2285-94. PubMed ID: 20570137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma.
    Sasahira T; Kirita T; Oue N; Bhawal UK; Yamamoto K; Fujii K; Ohmori H; Luo Y; Yasui W; Bosserhoff AK; Kuniyasu H
    Cancer Sci; 2008 Sep; 99(9):1806-12. PubMed ID: 18616526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma.
    Sasahira T; Kirita T; Nishiguchi Y; Kurihara M; Nakashima C; Bosserhoff AK; Kuniyasu H
    Oncotarget; 2016 May; 7(21):31137-52. PubMed ID: 27145272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-C is associated with lymphatic status and invasion in oral cancer.
    Siriwardena BS; Kudo Y; Ogawa I; Udagama MN; Tilakaratne WM; Takata T
    J Clin Pathol; 2008 Jan; 61(1):103-8. PubMed ID: 17351086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of oral cancer-associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma.
    Lin NN; Wang P; Zhao D; Zhang FJ; Yang K; Chen R
    J Oral Pathol Med; 2017 Jan; 46(1):21-30. PubMed ID: 27229731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
    Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
    Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer.
    Sasahira T; Bosserhoff AK; Kirita T
    Pathol Int; 2018 May; 68(5):278-286. PubMed ID: 29655307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
    Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression.
    Sasahira T; Nishiguchi Y; Fujiwara R; Kurihara M; Kirita T; Bosserhoff AK; Kuniyasu H
    Oncotarget; 2016 May; 7(18):26751-64. PubMed ID: 27050375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear STK15 expression is associated with aggressive behaviour of oral carcinoma cells in vivo and in vitro.
    Kao SY; Chen YP; Tu HF; Liu CJ; Yu AH; Wu CH; Chang KW
    J Pathol; 2010 Sep; 222(1):99-109. PubMed ID: 20597069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.